AU2018448845A1 — Method for producing dimethoxybenzene compound
Assigned to Taiho Pharmaceutical Co Ltd · Expires 2021-06-03 · 5y expired
What this patent protects
A method for producing a compound represented by formula (A-1) or a salt thereof, the method including a step in which either (S)-3-((3,5-dimethoxyphenyl)ethynyl)-1-(pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine or a salt thereof is reacted with a compound represented by f…
USPTO Abstract
A method for producing a compound represented by formula (A-1) or a salt thereof, the method including a step in which either (S)-3-((3,5-dimethoxyphenyl)ethynyl)-1-(pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine or a salt thereof is reacted with a compound represented by formula (I-1-A). (Formulae (I-1-A) and (A-1) are as described in the description.)
Drugs covered by this patent
- Lytgobi (futibatinib) · Taiho Oncology
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.